Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Chemfab Alka.
Quarter-by-quarter operating performance
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 73.30 | 79.08 | 79.58 | 86.33 | 82.31 | 76.53 | 81.90 | 83.62 | 92.32 | 91.54 | 76.56 | 68.14 | 74.78 |
| Expenses + | 48.77 | 63.59 | 68.70 | 71.13 | 69.98 | 68.20 | 71.75 | 71.71 | 78.98 | 80.24 | 71.10 | 66.21 | 66.26 |
| Operating Profit | 24.53 | 15.49 | 10.88 | 15.20 | 12.33 | 8.33 | 10.15 | 11.91 | 13.34 | 11.30 | 5.46 | 1.93 | 8.52 |
| OPM % | 33.47% | 19.59% | 13.67% | 17.61% | 14.98% | 10.88% | 12.39% | 14.24% | 14.45% | 12.34% | 7.13% | 2.83% | 11.39% |
| Other Income + | 1.50 | 3.68 | 1.46 | 1.51 | 1.90 | 2.59 | 0.60 | 2.55 | -8.51 | 1.36 | 1.76 | 2.77 | 2.80 |
| Interest | 0.04 | 0.05 | 0.06 | 0.43 | 0.41 | 0.94 | 1.22 | 1.20 | 1.57 | 1.57 | 1.94 | 2.03 | 2.14 |
| Depreciation | 5.46 | 5.42 | 5.62 | 5.45 | 5.86 | 7.31 | 8.80 | 9.62 | 10.61 | 6.39 | 6.61 | 7.47 | 7.95 |
| Profit before tax | 20.53 | 13.70 | 6.66 | 10.83 | 7.96 | 2.67 | 0.73 | 3.64 | -7.35 | 4.70 | -1.33 | -4.80 | 1.23 |
| Tax % | 25.62% | 30.58% | 35.44% | 34.35% | 32.04% | 66.67% | 172.60% | 48.08% | 25.03% | 45.74% | 51.13% | -7.08% | 60.16% |
| Net Profit + | 15.26 | 9.51 | 4.30 | 7.10 | 5.41 | 0.90 | -0.53 | 1.88 | -9.19 | 2.55 | -2.01 | -4.45 | 0.48 |
| EPS in Rs | 10.76 | 6.70 | 3.03 | 4.99 | 3.80 | 0.63 | -0.37 | 1.32 | -6.40 | 1.78 | -1.40 | -3.10 | 0.33 |
Financials of Chemfab Alka.
Annual income statement trend
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales + | 205 | 181 | 272 | 331 | 327 | 334 | 311 |
| Expenses + | 149 | 157 | 215 | 221 | 273 | 290 | 284 |
| Operating Profit | 55 | 24 | 57 | 111 | 55 | 44 | 27 |
| OPM % | 27% | 13% | 21% | 33% | 17% | 13% | 9% |
| Other Income + | -0 | 1 | 6 | 2 | 9 | -3 | 9 |
| Interest | 4 | 3 | 1 | 1 | 2 | 6 | 8 |
| Depreciation | 25 | 20 | 22 | 23 | 22 | 36 | 28 |
| Profit before tax | 27 | 2 | 39 | 89 | 39 | -0 | -0 |
| Tax % | 5% | 500% | 26% | 28% | 33% | 2,210% | 1,615% |
| Net Profit + | 25 | -8 | 29 | 65 | 26 | -7 | -3 |
| EPS in Rs | 18.26 | -5.78 | 20.34 | 45.54 | 18.50 | -4.83 | -2.39 |
| Dividend Payout % | 7% | 0% | 6% | 3% | 7% | -26% | -52% |
Financials of Chemfab Alka.
Capital structure and asset base
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
| Reserves | 262 | 253 | 284 | 347 | 373 | 366 | 361 |
| Borrowings + | 43 | 32 | 9 | 2 | 20 | 84 | 126 |
| Other Liabilities + | 30 | 36 | 46 | 48 | 93 | 57 | 76 |
| Total Liabilities | 348 | 335 | 352 | 412 | 500 | 522 | 577 |
| Fixed Assets + | 195 | 202 | 194 | 192 | 247 | 317 | 387 |
| CWIP | 35 | 3 | 8 | 31 | 74 | 36 | 31 |
| Investments | 1 | 24 | 31 | 68 | 5 | 16 | 14 |
| Other Assets + | 118 | 105 | 119 | 121 | 174 | 152 | 146 |
| Total Assets | 348 | 335 | 352 | 412 | 500 | 522 | 577 |
Financials of Chemfab Alka.
Operating, investing and financing cash movement
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 54 | 45 | 55 | 93 | 31 | 40 | 38 |
| Cash from Investing Activity + | -58 | -6 | -21 | -48 | -110 | -86 | -81 |
| Cash from Financing Activity + | 3 | -16 | -25 | -9 | 16 | 59 | 31 |
| Net Cash Flow | -1 | 23 | 9 | 36 | -62 | 13 | -12 |
| Free Cash Flow | -4 | 38 | 35 | 40 | -60 | -71 | -38 |
| CFO/OP | 110% | 157% | 107% | 97% | 74% | 104% | 140% |
Financials of Chemfab Alka.
Working capital efficiency and return ratios
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 17 | 31 | 29 | 24 | 24 | 23 | 28 |
| Inventory Days | 84 | 79 | 54 | 89 | 60 | 100 | 92 |
| Days Payable | 165 | 154 | 92 | 145 | 101 | 118 | 111 |
| Cash Conversion Cycle | -63 | -45 | -9 | -32 | -18 | 4 | 9 |
| Working Capital Days | -2 | 15 | 5 | 7 | -24 | 28 | 15 |
| ROCE % | 2% | 13% | 28% | 11% | 3% | 2% |
EBITDA margin improvement potential in explosive business to reach mid-teens (18-19% global benchmarks), with combined Solar-BME margins currently at 13-14%…
The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…